figuring out the actual risk of COX-2 inhibitors

March 2005

Experts are getting closer to figuring out the actual risk of COX-2 inhibitors...and how to use them appropriately.

The FDA will leave them on the market...with significant warnings.

Vioxx might even come back, now that we know cardiovascular problems aren't unique to Vioxx...and it's the ONLY one so far PROVEN to have GI benefits.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

figuring out the actual risk of COX-2 inhibitors
Insomnia a new sleeping pill called Lunesta
Cardiology concerns about Plavix and GI bleeding
new concern over Adderall (mixed amphetamines)
guidelines for treating migraines in CHILDREN
Gastroenterology whether chronic use of stimulant laxatives is harmful
Gastroenterology Is it important for patients to avoid aspirin and NSAIDs before fecal occult blood tests (Hemoccult, etc)
Gastroenterology drug doses need to be adjusted after bariatric surgery
Neurology & Pain Palladone, the first long-acting oral hydromorphone
Are all inhalation devices equally effective
Sudafed PE, a new version that DOESN'T contain pseudoephedrine
Dermatology benzoyl peroxide works as well as oral minocycline for mild to moderate facial acne
HIV & AIDS new recommendations for preventing HIV immediately AFTER an exposure
Drug Testing People are asking about drug testing

figuring out the actual risk of COX-2 inhibitors

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents